Chill Medicated

Chill Medicated has demonstrated a varied performance across different categories and states, with notable achievements and challenges. In Massachusetts, the brand has maintained a consistent presence in the Beverage category, holding the 5th position in January and February 2026, before slipping to 6th in March and April. Despite this slight decline in ranking, the sales figures show a more concerning trend, with a steady decrease from $117,236 in January to $82,338 in April. This suggests that while the brand remains competitive, it faces significant challenges in maintaining its market share. In the Topical category, Chill Medicated has shown remarkable stability, consistently ranking 3rd across all months, although sales have fluctuated slightly. The Tincture & Sublingual category presents a different picture, as the brand was only ranked in January, indicating a potential area for growth or concern, depending on market conditions and strategic priorities.

In Michigan, Chill Medicated has shown a strong performance, particularly in the Topical category, where it has consistently held the top position from January through April 2026. Sales in this category have shown a healthy upward trend, culminating in $433,586 in April, reflecting the brand's dominance and consumer preference in this segment. The Beverage category in Michigan tells a different story, with Chill Medicated improving its rank significantly from 9th in January to 3rd in February and March, before slightly dropping to 4th in April. Despite this minor dip, the sales figures in April remain robust, indicating a solid foothold in the Michigan beverage market. The brand's fluctuating rankings across these categories highlight both opportunities for reinforcement in its strongholds and potential strategic adjustments in more competitive areas.